文献速递冠心病血脂与心血管预防

LDL-C/HDL-C比值与早发冠心病病变严重程度及2年预后

[The impact of LDL-C/HDL-C ratio on severity of coronary artery disease and 2-year outcome in patients with premature coronary heart disease: results of a prospective, multicenter, observational cohort study].
PubMed 文献 · Zhonghua Xin Xue Guan Bing Za Zhi · 2023-01-01

高比值组冠脉病变更严重,2年MACCE发生率更高,但Cox多因素回归未显示比值与2年MACCE独立相关。

要点

  • 高LDL-C/HDL-C比值组冠脉病变更严重,三支病变比例更高。
  • 高比值组2年MACCE发生率显著高于低比值组(9.1%比6.9%)。
  • 多因素回归未显示LDL-C/HDL-C比值与2年MACCE独立相关。

核心结论

  • 高LDL-C/HDL-C比值与早发冠心病患者冠脉病变严重程度正相关。
  • 高比值患者2年MACCE发生率显著升高。
  • LDL-C/HDL-C比值可能作为评估冠脉病变严重程度及远期预后的指标。

研究设计与样本

  • 研究来源于PROMISE前瞻性、多中心、观察性队列研究。

主要发现

  • 高比值组靶病变个数(1.04±0.74比0.97±0.80,P=0.002)、冠脉病变支数(2.04±0.84比1.85±0.84,P<0.001)、术前SYNTAX评分(13.81±8.87比11.70±8.05,P<0.001)及三支病变比例(36.2%比27.4%,P<0.001)均高于低比值组。
  • 相关分析显示LDL-C/HDL-C比值与术前SYNTAX评分、冠脉病变支数、靶病变个数及三支病变均呈正相关(P均<0.05)。
  • 2年随访高比值组MACCE发生率显著高于低比值组(9.1%比6.9%,P=0.011)。
  • 两组全因死亡、心原性死亡、心肌梗死、卒中、血运重建及出血事件发生率差异无统计学意义(P>0.05)。
  • Cox多因素回归显示LDL-C/HDL-C比值与2年MACCE、全因死亡、心肌梗死、血运重建、卒中及BARC≥2型出血事件无相关性(P>0.05)。

临床怎么用

  • 在早发冠心病患者中可关注LDL-C/HDL-C比值以辅助评估冠脉病变严重程度。
  • 高LDL-C/HDL-C比值患者2年MACCE风险较高,可能需加强随访。
  • LDL-C/HDL-C比值是否可作为独立预后指标尚需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To explore the relationship between low density lipoprotein cholesterol (LDL-C)/high density lipoprotein cholesterol (HDL-C) ratio with the severity of coronary artery disease and 2-yeat outcome in patients with premature coronary heart disease. Methods: This prospective, multicenter, observational cohort study is originated from the PROMISE study. Eighteen thousand seven hundred and one patients with coronary heart disease (CHD) were screened from January 2015 to May 2019. Three thousand eight hundred and sixty-one patients with premature CHD were enrolled in the current study. According to the median LDL-C/HDL-C ratio (2.4), the patients were divided into two groups: low LDL-C/HDL-C group (LDL-C/HDL-C≤2.4, n=1 867) and high LDL-C/HDL-C group (LDL-C/HDL-C>2.4, n=1 994). Baseline data and 2-year major adverse cardiovascular and cerebrovascular events (MACCE) were collected and analyzed in order to find the differences between premature CHD patients at different LDL-C/HDL-C levels, and explore the correlation between LDL-C/HDL-C ratio with the severity of coronary artery disease and MACCE. Results: The average age of the low LDL-C/HDL-C ratio group was (48.5±6.5) years, 1 154 patients were males (61.8%); the average age of high LDL-C/HDL-C ratio group was (46.5±6.8) years, 1 523 were males (76.4%). The number of target lesions, the number of coronary artery lesions, the preoperative SNYTAX score and the proportion of three-vessel coronary artery disease in the high LDL-C/HDL-C group were significantly higher than those in the low LDL-C/HDL-C group (1.04±0.74 vs. 0.97±0.80, P=0.002; 2.04±0.84 vs. 1.85±0.84, P<0.001; 13.81±8.87 vs. 11.70±8.05, P<0.001; 36.2% vs. 27.4%, respectively, P<0.001). Correlation analysis showed that there was a significant positive correlation between LDL-C/HDL-C ratio and preoperative SYNTAX score, the number of coronary artery lesions, the number of target lesions and whether it was a three-vessel coronary artery disease (all P<0.05). The 2-year follow-up results showed that the incidence of MACCE was significantly higher in the high LDL-C/HDL-C group than that in the low LDL-C/HDL-C group (6.9% vs. 9.1%, P=0.011). There was no significant difference in the incidence of all-cause death, cardiac death, myocardial infarction, stroke, revascularization and bleeding between the two groups. Cox multivariate regression analysis showed that the LDL-C/HDL-C ratio has no correlation with 2-year MACCE, death, myocardial infarction, revascularization, stroke and bleeding events above BARC2 in patients with premature CHD. Conclusion: High LDL-C/HDL-C ratio is positively correlated with the severity of coronary artery disease in patients with premature CHD. The incidence of MACCE of patients with high LDL-C/HDL-C ratio is significantly higher during 2 years follow-up; LDL-C/HDL-C ratio may be an indicator for evaluating the severity of coronary artery disease and long-term prognosis in patients with premature CHD. 目的: 比较早发冠心病患者低密度脂蛋白胆固醇(LDL-C)/高密度脂蛋白胆固醇(HDL-C)比值,探讨其与早发冠心病患者冠状动脉(冠脉)病变严重程度和远期不良事件的相关性,以及其在早发冠心病中的临床应用价值。 方法: 本研究来源于PROMISE研究。PROMISE研究是一项前瞻性、多中心、观察性队列研究,入选2015年1月至2019年5月确诊冠心病的患者18 701例。本研究纳入其中的早发冠心病患者3 861例,根据LDL-C/HDL-C比值的中位数(2.4)将患者分为低LDL-C/HDL-C组(LDL-C/HDL-C≤2.4,n=1 867)和高LDL-C/HDL-C组(LDL-C/HDL-C>2.4,n=1 994)。收集基线资料,并进行2年长期随访,记录主要不良心脑血管事件(MACCE)的发生情况,比较不同LDL-C/HDL-C水平早发冠心病患者之间的差异,分析LDL-C/HDL-C比值与患者冠脉病变严重程度及MACCE的相关性。 结果: 低LDL-C/HDL-C组年龄(48.5±6.5)岁,男性1 154例(61.8%);高LDL-C/HDL-C组年龄(46.5±6.8)岁,男性1 523例(76.4%)。高LDL-C/HDL-C组靶病变个数、冠脉病变支数、术前SNYTAX评分及三支病变的比例均高于低LDL-C/HDL-C组[分别为:(1.04±0.74)个比(0.97±0.80)个,P=0.002;(2.04±0.84)支比(1.85±0.84)支,P<0.001;(13.81±8.87)分比(11.70±8.05)分,P<0.001;36.2%比27.4%,P<0.001]。相关分析显示LDL-C/HDL-C比值与术前SYNTAX评分、冠脉病变支数、靶病变个数以及是否为三支病变之间均存在正相关性(P均<0.05)。2年随访结果显示,与低LDL-C/HDL-C组相比,高LDL-C/HDL-C组MACCE事件发生率较高(6.9%比9.1%,P=0.011)。两组间全因死亡、心原性死亡、心肌梗死、卒中、血运重建及出血事件的发生率差异无统计学意义(P>0.05)。Cox多因素回归分析显示,LDL-C/HDL-C比值与早发冠心病患者2年内MACCE、全因死亡、心肌梗死、血运重建、卒中及出血学术研究联合会2型以上出血事件无相关性(P>0.05)。 结论: 高LDL-C/HDL-C比值与早发冠心病患者冠脉病变的严重程度正相关,且高LDL-C/HDL-C比值的患者2年MACCE事件发生率升高;LDL-C/HDL-C比值可能可以作为评价早发冠心病患者冠脉病变严重程度及远期预后的一项指标。.

来源:Zhonghua Xin Xue Guan Bing Za Zhi,查看原文。版权归原作者所有。

引用

  1. Xu JJ, Chen J, Liu YX, et al. [The impact of LDL-C/HDL-C ratio on severity of coronary artery disease and 2-year outcome in patients with premature coronary heart disease: results of a prospective, multicenter, observational cohort study]. Zhonghua Xin Xue Guan Bing Za Zhi. 2023. PMID: 37460423. doi:10.3760/cma.j.cn112148-20230128-00043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。